Patent ID: 6676947
Filing Date: 2004-01-13
Classification: A61K,A61P

Abstract:
A method for treating primary haemochromatoses in a patient, which comprises administering to the patient a combination therapy comprising (i) an erythropoietin preparation in an amount ranging from 500 to 5,000 U of erythropoietin and (ii) a calcium preparation consisting of 20 to 500 mg of calcium, wherein the erythropoietin preparation and the calcium preparation are each administered from 1 to 5 times weekly with the total amount of erythropoietin administered to the patient not exceeding 5,000 U per week and the total amount of calcium administered to the patient not exceeding 2,000 mg per week, the combination therapy being administered for a period of time sufficient to reduce the severity of the primary haemochromatoses.